MS Medications: Injections, Infusions, and Oral Drugs

Multiple sclerosis (MS) drugs can modify disease progression, treat relapses, and more. Learn about over 50 MS drugs, like Tecfidera and Ocrevus.

LC/MS/MS Method Package for Veterinary Drugs Ver. 2 : SHIMADZU (Shimadzu Corporation)

Method package including 129 veterinary drug compounds, more than 3 times as many as Ver. 1 ; High-speed method with just 16.5 mins detection time ; Pretreatment program to improve the peak shape for polar veterinary drug compounds

MS drug development poses a big challenge for pharma

[Reporter's View] ‘Tyranny of Drug Committees persist' ; [Reporter’s View] Vaccine sovereignty only during epidemics ; [Reporter's View] pros and cons of concurrent reimb listing

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic - NPR

January 20, 2020 · 9:00 AM ET · By Sydney Lupkin ; "They are extremely expensive," says Ewing-Wilson. On average, the medicines cost $70,000 per year, according to a 2017 study. Some prices have increased fivefold from when the drugs were first approved by the Food and Drug Administration. Even with insurance, says Ewing-Wilson, patients can be left on the hook for anywhere from $3,000 to more than $50,000 a year. Some patients tell her they need to skip their medications altogether because they're unaffordable. ...

Researchers see success in trial for first generic MS drug, paving way for more

For the first time, a generic version of a popular drug for multiple sclerosis (MS) was found to be safe and effective— which may set precedent for generic drug development for MS patients.

MS drug almost halves hospitalised patients' risk of severe Covid symptoms

A drug used for multiple sclerosis nearly halves the chance of developing severe coronavirus symptoms in hospitalised patients and may prevent deaths, a new trial has shown...

Sanofi's mixed fortunes in MS drug trials has market focus on win

Sanofi's most advanced multiple sclerosis drug candidate has missed the main goal of two late-stage trials to treat relapsing forms of the disease, but in a positive surprise succeeded in a study o...

Tysabri Treatment for Multiple Sclerosis

Tysabri is a drug used to treat multiple sclerosis (MS). WebMD explains how it works.

Acorda regains ex-U.S. rights of MS drug Fampyra from Biogen

With sales declining for aging MS drug Fampyra, Biogen has exercised an option to return licensing rights outside of the U.S. to Acorda Therapeutics.

Merck KGaA suffers major blow as MS drug fails in late-stage trials

Merck KGaA's experimental multiple sclerosis (MS) drug missed the primary goal in highly anticipated late-stage trials, dealing a major blow to the German company's growth ambitions and hitting its...